Guy Wendy purchased $5K of PCSA
Guy Wendy (Chief Administrative Officer) purchased 2,118 shares of Processa Pharmaceuticals, Inc. (PCSA) at $2.22 on 2026-06-15.
How this was made
The 30-second read
Why it matters
The newest fact is the reported open-market purchase by Guy Wendy (Chief Administrative Officer) at a stated price and share count; it may slightly influence sentiment but lacks fundamental drivers.
Market read
Traders may note the insider buy as a minor positive signal, but there is no new business or financial catalyst.
What to watch
Transaction size is small relative to typical institutional flows; also no guidance/clinical/regulatory updates are provided in the filing.
Background
The article is an SEC Form 4 insider transaction disclosure from Processa Pharmaceuticals, Inc.
Ticker impact
Processa Pharmaceuticals insider Form 4 shows CFO/CAO Guy Wendy bought 2,118 shares at $2.2200 on 2026-06-15.
Likely limited near-term impact; any effect would be sentiment-driven and small.
The filing is a routine insider transaction with no accompanying operational, regulatory, or financial disclosure.
Market effects
No sector-level read-across; this is company-specific insider activity.
None indicated.
None indicated.
Counterpoint
Insider buys can be discretionary and may not reflect a change in fundamentals, especially without a 10b5-1 plan context.
Key entities
- issuerProcessa Pharmaceuticals, Inc.
Company whose shares were purchased by an insider, disclosed via SEC Form 4.
- insiderGuy Wendy
Chief Administrative Officer who reported an open-market purchase of PCSA shares.
